The Amyloidosis Channel is supported with funding from Prothena (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
VJVirtual | Blood mass-spectrometry for detecting disease progression
Angela Dispenzieri
• 1 May 2020
Angela Dispenzieri, MD, of the Mayo Clinic College of Medicine, Rochester, MN, outlines the use of blood mass-spectrometry to detect immunoglobulins in amyloidosis as a measure of disease progression. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).
